Page last updated: 2024-09-04

torcetrapib and Heart Diseases

torcetrapib has been researched along with Heart Diseases in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (71.43)	29.6817
2010's	2 (28.57)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
McCullough, PA; Shin, HJ	1
Katsnelson, A	1
Tanne, JH	1
Healy, B	1
Honey, K	1
Asztalos, BF; Schaefer, EJ	1
Duriez, P	1

Reviews

2 review(s) available for torcetrapib and Heart Diseases

Article	Year
Focus on lipids: high-density lipoprotein cholesterol and its associated lipoproteins in cardiac and renal disease. Nephron. Clinical practice, 2014, Volume: 127, Issue:1-4 Topics: Amides; Apolipoprotein A-I; Benzodiazepines; Black or African American; Cholesterol Ester Transfer Proteins; Cholesterol Esters; Cholesterol, HDL; Cholesterol, LDL; Cohort Studies; Esters; Heart Diseases; Humans; Hyperlipoproteinemias; Kidney Diseases; Liver; Niacin; Observational Studies as Topic; Oxazolidinones; Prospective Studies; Quinolines; Randomized Controlled Trials as Topic; Risk; Sulfhydryl Compounds; Triglycerides; White People	2014
Where are we with high-density lipoprotein raising and inhibition of cholesteryl ester transfer for heart disease risk reduction? Current opinion in cardiology, 2007, Volume: 22, Issue:4 Topics: Animals; Anticholesteremic Agents; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Heart Diseases; Humans; Quinolines; Randomized Controlled Trials as Topic; Risk Factors	2007

Article

Year

Focus on lipids: high-density lipoprotein cholesterol and its associated lipoproteins in cardiac and renal disease.

Nephron. Clinical practice, 2014, Volume: 127, Issue:1-4

Topics: Amides; Apolipoprotein A-I; Benzodiazepines; Black or African American; Cholesterol Ester Transfer Proteins; Cholesterol Esters; Cholesterol, HDL; Cholesterol, LDL; Cohort Studies; Esters; Heart Diseases; Humans; Hyperlipoproteinemias; Kidney Diseases; Liver; Niacin; Observational Studies as Topic; Oxazolidinones; Prospective Studies; Quinolines; Randomized Controlled Trials as Topic; Risk; Sulfhydryl Compounds; Triglycerides; White People

2014

Where are we with high-density lipoprotein raising and inhibition of cholesteryl ester transfer for heart disease risk reduction?

Current opinion in cardiology, 2007, Volume: 22, Issue:4

Topics: Animals; Anticholesteremic Agents; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Heart Diseases; Humans; Quinolines; Randomized Controlled Trials as Topic; Risk Factors

2007

Trials

1 trial(s) available for torcetrapib and Heart Diseases

Article	Year
Drug designed to raise HDL levels falls down. The Journal of clinical investigation, 2007, Volume: 117, Issue:2 Topics: Anticholesteremic Agents; Atorvastatin; Cholesterol Ester Transfer Proteins; Drug Industry; Heart Diseases; Heptanoic Acids; Humans; Lipoproteins, HDL; Pyrroles; Quinolines	2007

Other Studies

4 other study(ies) available for torcetrapib and Heart Diseases

Article	Year
Good news for 'good' cholesterol. Nature, 2010, Nov-18, Volume: 468, Issue:7322 Topics: Amides; C-Reactive Protein; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Esters; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Oxazolidinones; Quinolines; Sulfhydryl Compounds	2010
Pfizer stops clinical trials of heart drug. BMJ (Clinical research ed.), 2006, Dec-16, Volume: 333, Issue:7581 Topics: Anticholesteremic Agents; Cholesterol, HDL; Clinical Trials, Phase III as Topic; Drug Approval; Drug Industry; Heart Diseases; Humans; Quinolines; United States	2006
Solving the HDL mystery. U.S. news & world report, 2006, Dec-18, Volume: 141, Issue:23 Topics: Cholesterol, HDL; Heart Diseases; Humans; Quinolines; United States	2006
Treating high-density lipoprotein cholesterol: a return to inhibition of cholesteryl ester transfer protein? Current atherosclerosis reports, 2008, Volume: 10, Issue:3 Topics: Anticholesteremic Agents; Atherosclerosis; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Cholesterol, LDL; Dyslipidemias; Heart Diseases; Humans; Oxazolidinones; Quinolines; Risk Factors	2008